Inflammation Models | Charles River Discovery Research Services

Bleomycin-Induced Pulmonary Fibrosis Model 

Charles River offers models of acute inflammatory lung disease. Instillation of bleomycin into the lungs results in acute inflammation followed by a more chronic fibrotic response. Treatment can be initiated at earlier or later time points to assess the effects of candidate agents on either aspect of this model. LPS instillation (model currently under development) can be used as a model of the inflammatory response to infectious agents. Histologic, biochemical and cellular end points are used to monitor efficacy. Additionally, the use of activatable fluorescence probes permits the in vivo assessment of the activity of relevant proteases, such as cathepsins, elastase and MMPs.

For more information about our Bleomycin-Induced Pulmonary Fibrosis model, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.